Finding. The high-fat plus L-NAME mouse is not one heart-failure. Sun, Young, McMullen and colleagues show older females on low-dose NOS inhibition get a HFpEF-like heart: stiff diastole, poor exercise, systole intact. Turn the dose up and females add inflammatory transcription without more diastolic wreckage. Males on high dose become hypertensive and systolic-failed, a HFrEF-like picture. Blood lipids remodel sphingolipids and phospholipids in both sexes, with sex-specific phosphatidylinositol and lysophosphatidylcholine. Heart RNA shares matrix, calcium-handling, and metabolic paths.
Score 71. Sex-dose split of a workhorse model. Mitochondria inferred. Confidence is medium.
What to do with it Do not cite a single L-NAME+HFD paper as HFpEF without naming sex and dose.
